Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Malignant Solid Neoplasm
Interventions: PROCEDURE: Biopsy|PROCEDURE: Biospecimen Collection|PROCEDURE: Echocardiography|BIOLOGICAL: Pertuzumab|PROCEDURE: Radiologic Examination|BIOLOGICAL: Trastuzumab
Sponsor: National Cancer Institute (NCI)